Private Wealth Management Group, LLC Pharma Cyte Biotech, Inc. Transaction History
Private Wealth Management Group, LLC
- $221 Billion
- Q1 2024
A detailed history of Private Wealth Management Group, LLC transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 42 shares of PMCB stock, worth $86. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 42
-0.0%
Holding current value
$86
Previous $91,000
9.89%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PMCB
# of Institutions
32Shares Held
1.07MCall Options Held
5.4KPut Options Held
400-
K2 Principal Fund, L.P. Toronto, A6328KShares$674,6560.27% of portfolio
-
Geode Capital Management, LLC Boston, MA200KShares$412,5780.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA175KShares$359,6800.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$189,6997.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$170,4170.12% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $42.7M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...